Center for Systems Biology and Molecular Medicine

Dr. Mohan B Appaiahgari is a Virologist by education and research training. He obtained master’s degree in virology from Sri Venkateswara University, Tirupati, and doctoral degree in virology-cum-biotechnology from Jamia Hamdard, New Delhi. He has strong inclination for translational research and his notable achievements include identification of potential biomarkers, development of novel vaccine candidates having commercialization potential, identification of novel antiviral therapeutic candidates, clinical development of a human vaccine, etc. Besides, he has ongoing interests in basic, translational and diagnostic virology. Post-Ph.D., he briefly worked as an awardee at THSTI, Faridabad, and later joined as Faculty Scientist. He published in various international journals and also has patents to his credit. In 2018, he founded a startup and pursued a BIRAC-funded project on the development of a novel poultry vaccine, wherein its superiority over existing vaccine is successfully established. Recently, through collaborative efforts, they identified novel drug targets in SARS-CoV-2 replication. Dr. Mohan B Appaiahgari received the Vaccine Research Innovation (VRI) award from DBT for the year 2008 to carry out post-doctoral research in translational sciences at THSTI, Faridabad. He worked as VRI awardee between October 2008 and November 2009, during which time he conceived a project on the development of novel animal adenovirus-based gene/vaccine delivery vector systems for potential human and animal use. As part of this, he has isolated several novel animal adenoviruses from a variety of animal species. Later, he also received a DBT-funded grant for their characterization and currently he is pursuing the same to explore the vectorial properties of these novel animal adenoviruses.